Revelation Stock Analysis

The current indifference towards the small price fluctuations of Revelation Biosciences created some momentum for investors as it was traded today as low as 0.0 and as high as 0.0 per share. The company executives did not add any value to Revelation Biosciences investors in December. However, most investors can still diversify their portfolios with Revelation Biosciences to hedge their inherited risk against high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently very low. The very small Stock volatility is a good signal to investors with longer-term investment horizons.
Check out Your Equity Center.

Revelation Stock Analysis 

The Revelation Biosciences stock analysis report makes it easy to digest most publicly released information about Revelation Biosciences and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Revelation Stock analysis module also helps to analyze the Revelation Biosciences price relationship with some important fundamental indicators such as market cap and management efficiency.

Revelation Stock Analysis Notes

About 13.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.88. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Revelation Biosciences had not issued any dividends in recent years. Revere Bank, a state chartered bank, provides various commercial banking products and services for individuals, businesses, and professionals. The company was founded in 2007 and is headquartered in Rockville, Maryland. REVERE BK operates under BanksRegional classification in USA and is traded on BATS Exchange. It employs 243 people. To find out more about Revelation Biosciences contact the company at 301-841-9600 or learn more at

Revelation Biosciences Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Revelation Biosciences' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Revelation Biosciences or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Revelation Biosciences is not yet fully synchronised with the market data
Revelation Biosciences has some characteristics of a very speculative penny stock
Revelation Biosciences has high likelihood to experience some financial distress in the next 2 years
About 13.0% of the company outstanding shares are owned by corporate insiders

Revelation Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 270.49 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Revelation Biosciences's market, we take the total number of its shares issued and multiply it by Revelation Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Revelation Profitablity

Revelation Biosciences' profitability indicators refer to fundamental financial ratios that showcase Revelation Biosciences' ability to generate income relative to its revenue or operating costs. If, let's say, Revelation Biosciences is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Revelation Biosciences' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Revelation Biosciences' profitability requires more research than a typical breakdown of Revelation Biosciences' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 34.87 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 49.7 %, which suggests for every 100 dollars of sales, it generated a net operating income of 0.5.

Management Efficiency

The entity has return on total asset (ROA) of 1.2 % which means that it generated profit of $1.2 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of 11.15 %, meaning that it created $11.15 on every $100 dollars invested by stockholders. Revelation Biosciences management efficiency ratios could be used to measure how well revelation biosciences manages its routine affairs as well as how well it operates its assets and liabilities.

Revelation Biosciences Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Revelation Biosciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Revelation Biosciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Revelation Biosciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Revelation Biosciences Technical and Predictive Indicators

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Revelation Biosciences to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Sync Your Broker Now


Sync Your Broker

Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
All  Next Launch Module
Check out Your Equity Center. Note that the Revelation Biosciences information on this page should be used as a complementary analysis to other Revelation Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Tools for Revelation Stock

When running Revelation Biosciences price analysis, check to measure Revelation Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revelation Biosciences is operating at the current time. Most of Revelation Biosciences' value examination focuses on studying past and present price action to predict the probability of Revelation Biosciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Revelation Biosciences' price. Additionally, you may evaluate how the addition of Revelation Biosciences to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bond Directory
Find actively traded corporate debentures issued by US companies
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Transaction History
View history of all your transactions and understand their impact on performance